Respiratory Muscle Training in Scleroderma
ConditionScleroderma (Limited and Diffuse)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorFirat University
About this trial
The aim of this study is to investigate the effects of IMT on respiratory muscle strength, pulmonary function tests, quality of life aerobic capacity, dyspnea, fatigue and physical activity level in scleroderma patients with ILD. The study will include 30 Scleroderma + ILD patients who are under follow-up in Fırat University Rheumatology Department. Patients will be randomly divided into two groups. High intensity intermittent inspiratory muscle training (H-IMT) will be applied to the respiratory muscle training group in addition to the exercise program. Respiratory muscle strength will be assessed by maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP); aerobic capacity will be assessed by exercise test and VO2max. Dyspnea will be assessed with the Modified Medical Research Council Scale; fatigue with the Fatigue Severity Scale; quality of life with the Scleroderma Health Assessment Questionnaire; physical activity level with the International Physical Activity Scale - Short Form
Eligibility criteria
Qualifiers
18-65 years old
Patients whose medical treatment has not changed in the last three months
Patients who volunteered to participate in the study and were cooperative
Literate patients
Disqualifiers
Patients who are pregnant
Patients with a diagnosis of malignancy
Patients with other concomitant systemic inflammatory rheumatic diseases
Patients with neurological, orthopedic or congenital problems that prevent physical activity
Trial design
Treatments tested in this trial
- Inspiratory muscle training
- Exercise
Treatment groups
30 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov